Nyamba, Isaïe ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Jennotte, Olivier ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Charles B Sombié; Université Joseph Ki Zerbo > Pharmacie
Lechanteur, Anna ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Sacre, Pierre-Yves ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Abdoulaye Djandé; Université Joseph Ki Zerbo > Chimie
Rasmane Semde; Université Joseph Ki Zerbo > Pharmacie
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion
Alternative titles :
[fr] Étude de préformulation pour la sélection d'un polymère approprié pour le développement d'une dispersion solide à base d'acide ellagique par extrusion à chaud
Original title :
[en] Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion
Alsulays, B.B., Park, J.B., Alshehri, S.M., Morott, J.T., Alshahrani, S.M., Tiwari, R.V., Alshetaili, A.S., Majumdar, S., Langley, N., Kolter, K., Gryczke, A., Repka, M.A., Influence of molecular weight of carriers and processing parameters on the extrudability, drug release, and stability of fenofibrate formulations processed by hot-melt extrusion. J. Drug Deliv. Sci. Technol. 29 (2015), 189–198, 10.1016/j.jddst.2015.07.011.
Anane-Adjei, A.B., Jacobs, E., Nash, S.C., Askin, S., Soundararajan, R., Kyobula, M., Booth, J., Campbell, A., Amorphous solid dispersions: Utilization and challenges in preclinical drug development within AstraZeneca. Int. J. Pharm., 614, 2022, 121387, 10.1016/j.ijpharm.2021.121387.
Anderson, B.D., Predicting Solubility / Miscibility in Amorphous Dispersions : It Is Time to Move Beyond Regular Solution Theories. J. Pharm. Sci. 107 (2018), 24–33, 10.1016/j.xphs.2017.09.030.
Arulmozhi, V., Pandian, K., Mirunalini, S., Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surfaces B Biointerfaces 110 (2013), 313–320, 10.1016/j.colsurfb.2013.03.039.
Asati Amit, V., Salunkhe Kishor, S., Chavan Machindra, J., Chintamani Ravindra, B., Pratap, R.S.R., Solubility enhancement of BCS classified IV drug-apixaban by preparation and evaluation of mesoporous nanomatrix. Int. J. Res. Pharm. Sci. 11 (2020), 880–890, 10.26452/ijrps.v11i1.1910.
Avachat, A.M., Patel, V.G., Self nanoemulsifying drug delivery system of stabilized ellagic acid-phospholipid complex with improved dissolution and permeability. Saudi Pharm. J. 23 (2015), 276–289, 10.1016/j.jsps.2014.11.001.
Ayad, M.H., Rational formulation strategy from drug discovery profiling to human proof of concept Rational formulation strategy from drug discovery profiling to human proof of concept. Drug delivery 22:6 (2015), 877–884, 10.3109/10717544.2014.898714.
Bala, I., Bhardwaj, V., Hariharan, S., Sitterberg, J., Bakowsky, U., Ravi Kumar, M.N.V., Design of biodegradable nanoparticles: A novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology 16 (2005), 2819–2822, 10.1088/0957-4484/16/12/014.
Bala, I., Bhardwaj, V., Hariharan, S., Kumar, M.N.V.R., Analytical methods for assay of ellagic acid and its solubility studies. J. Pharm. Biomed. Anal. 40 (2006), 206–210, 10.1016/j.jpba.2005.07.006.
Dávalos, J.Z., Lima, C.F.R.A.C., Santos, L.M.N.B.F., Romero, V.L., Liebman, J.F., Thermochemical and structural studies of gallic and ellagic acids. J. Chem. Thermodyn. 129 (2019), 108–113, 10.1016/j.jct.2018.09.027.
Dell'Agli, M., Galli, G.V., Corbett, Y., Taramelli, D., Lucantoni, L., Habluetzel, A., Maschi, O., Caruso, D., Giavarini, F., Romeo, S., Bhattacharya, D., Bosisio, E., Antiplasmodial activity of Punica granatum L. fruit rind. J. Ethnopharmacol. 125 (2009), 279–285, 10.1016/j.jep.2009.06.025.
Djuris, J., Nikolakakis, I., Ibric, S., Djuric, Z., Kachrimanis, K., Preparation of carbamazepine-Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting. Eur. J. Pharm. Biopharm., 2013, 10.1016/j.ejpb.2012.12.018.
Emam, M.h.F., Taha, N.F., Emara, L.H., A novel combination of Soluplus® and Poloxamer for Meloxicam solid dispersions via hot melt extrusion for rapid onset of action—part 1: dissolution and stability studies. J. Appl. Pharm. Sci. 11 (2021), 141–150, 10.7324/JAPS.2021.110218.
Gallardo, D., Skalsky, B., Kleinebudde, P., Controlled release solid dosage forms using combinations of (meth)acrylate copolymers. Pharm. Dev. Technol. 13 (2008), 413–423, 10.1080/10837450802202098.
Ghosh, I., Vippagunta, R., Li, S., Vippagunta, S., Key considerations for optimization of formulation and melt-extrusion process parameters for developing thermosensitive compound. Pharm. Dev. Technol. 17 (2012), 502–510, 10.3109/10837450.2010.550624.
Göke, K., Lorenz, T., Repanas, A., Schneider, F., Steiner, D., Baumann, K., Bunjes, H., Dietzel, A., Finke, J.H., Glasmacher, B., Kwade, A., Novel strategies for the formulation and processing of poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 126 (2018), 40–56, 10.1016/j.ejpb.2017.05.008.
Gottschalk, T., Özbay, C., Feuerbach, T., Thommes, M., Predicting Throughput and Melt Temperature in Pharmaceutical Hot Melt Extrusion. Pharmaceutics, 14(9), 2022, 1757.
Grignard, E., Taylor, R., McAllister, M., Box, K., Fotaki, N., Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies. Eur. J. Pharm. Sci. 99 (2017), 193–201, 10.1016/j.ejps.2016.12.004.
Guan, J., Jin, L., Liu, Q., Xu, H., Wu, H., Zhang, X., Mao, S., Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption. Eur. J. Pharm. Sci., 139, 2019, 105043, 10.1016/j.ejps.2019.105043.
Guo, Z., Lu, M., Li, Y., Pang, H., Lin, L., Liu, X., Wu, C., The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. J. Pharm. Pharmacol. 66 (2014), 285–296, 10.1111/jphp.12145.
Haser, A., Huang, S., Listro, T., White, D., Zhang, F., An approach for chemical stability during melt extrusion of a drug substance with a high melting point. Int. J. Pharm., 2017, 10.1016/j.ijpharm.2017.03.070.
Haser, A., Huang, S., Listro, T., White, D., Zhang, F., An approach for chemical stability during melt extrusion of a drug substance with a high melting point. Int. J. Pharm. 524 (2017), 55–64, 10.1016/j.ijpharm.2017.03.070.
Hou, Y., Shao, J., Fu, Q., Li, J., Sun, J., He, Z., Spray-dried nanocrystals for a highly hydrophobic drug: Increased drug loading, enhanced redispersity, and improved oral bioavailability. Int. J. Pharm. 516 (2017), 372–379, 10.1016/j.ijpharm.2016.11.043.
Huang, Y., Dai, W.-G., Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm. Sin. B 4 (2014), 18–25, 10.1016/j.apsb.2013.11.001.
Huang, D., Xie, Z., Rao, Q., Liamas, E., Pan, P., Guan, S., Zhang, Z.J., Lu, M., Li, Q., Hot melt extrusion of heat-sensitive and high melting point drug: Inhibit the recrystallization of the prepared amorphous drug during extrusion to improve the bioavailability. Int. J. Pharm. 565 (2019), 316–324, 10.1016/j.ijpharm.2019.04.064.
Hughey, J.R., Keen, J.M., Brough, C., Saeger, S., McGinity, J.W., Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: The utility of KinetiSol ® Dispersing. Int. J. Pharm. 419 (2011), 222–230, 10.1016/j.ijpharm.2011.08.007.
Hughey, J.R., Keen, J.M., Miller, D.A., Kolter, K., Langley, N., McGinity, J.W., The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Eur. J. Pharm. Sci. 48 (2013), 758–766, 10.1016/j.ejps.2013.01.004.
Hussein, M.Z., Al Ali, S.H., Zainal, Z., Hakim, M.N., Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent. Int. J. Nanomedicine 6 (2011), 1373–1383, 10.2147/ijn.s21567.
Iyer, R., Jovanovska, V.P., Berginc, K., Jaklič, M., Fabiani, F., Harlacher, C., Huzjak, T., Sanchez-Felix, M.V., Amorphous solid dispersions (ASDs): The influence of material properties, manufacturing processes and analytical technologies in drug product development. Pharmaceutics, 13, 2021, 10.3390/pharmaceutics13101682.
Jankovic, S., Tsakiridou, G., Ditzinger, F., Koehl, N.J., Price, D.J., Ilie, A.R., Kalantzi, L., Kimpe, K., Holm, R., Nair, A., Griffin, B., Saal, C., Kuentz, M., Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs – a PEARRL review. J. Pharm. Pharmacol. 71 (2019), 441–463, 10.1111/jphp.12948.
Janssens, S., Van den Mooter, G., Physical chemistry of solid dispersions. J. Pharm. Pharmacol. 61:12 (2009), 1571–1586, 10.1211/jpp/61.12.0001.
Juppo, A.M., Boissier, C., Khoo, C., Evaluation of solid dispersion particles prepared with SEDS. Int. J. Pharm. 250 (2003), 385–401, 10.1016/S0378-5173(02)00577-X.
Kanaujia, P., Poovizhi, P., Ng, W.K., Tan, R.B.H., Amorphous formulations for dissolution and bioavailability enhancement of poorly soluble APIs. Powder Technol. 285 (2015), 2–15, 10.1016/j.powtec.2015.05.012.
Kong, Y., Wang, W., Wang, C., Li, L., Peng, D., Tian, B., Supersaturation and phase behavior during dissolution of amorphous solid dispersions. Int. J. Pharm., 631, 2023, 122524, 10.1016/j.ijpharm.2022.122524.
LaFountaine, J.S., McGinity, J.W., Williams, R.O., Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review. AAPS PharmSciTech 17 (2016), 43–55, 10.1208/s12249-015-0393-y.
Li, B., Harich, K., Wegiel, L., Taylor, L.S., Edgar, K.J., Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. Carbohydr. Polym. 92 (2013), 1443–1450, 10.1016/j.carbpol.2012.10.051.
Li, J., Lee, I.W., Shin, G.H., Chen, X., Park, H.J., Curcumin-Eudragit® e PO solid dispersion: A simple and potent method to solve the problems of curcumin. Eur. J. Pharm. Biopharm. 94 (2015), 322–332, 10.1016/j.ejpb.2015.06.002.
Li, J., Lee, I.W., Shin, G.H., Chen, X., Park, H.J., Curcumin-Eudragit® e PO solid dispersion: A simple and potent method to solve the problems of curcumin. Eur. J. Pharm. Biopharm., 2015, 10.1016/j.ejpb.2015.06.002.
Li, H., Zhang, M., Xiong, L., Feng, W., Williams, R.O., Bioavailability improvement of carbamazepine via oral administration of modified-release amorphous solid dispersions in rats. Pharmaceutics 12 (2020), 1–16, 10.3390/pharmaceutics12111023.
Li, Y., Zhao, X., Zu, Y., Zhang, Y., Ge, Y., Zhong, C., Wu, W., Preparation and characterization of micronized ellagic acid using antisolvent precipitation for oral delivery. Int. J. Pharm. 486 (2015), 207–216, 10.1016/j.ijpharm.2015.03.071.
Li, Y., Zhang, Y., Dai, W., Zhang, Q., Enhanced oral absorption and anti-inflammatory activity of ellagic acid via a novel type of case in nanosheets constructed by simple coacervation. Int. J. Pharm., 594, 2021, 120131, 10.1016/j.ijpharm.2020.120131.
Liu, J., Cao, F., Zhang, C., Ping, Q., Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion. Acta Pharm. Sin. B 3 (2013), 263–272, 10.1016/j.apsb.2013.06.007.
Liu, X., Feng, X., Williams, R.O., Zhang, F., Characterization of amorphous solid dispersions. J. Pharm. Investig. 48 (2018), 19–41, 10.1007/s40005-017-0361-5.
Liu, H., Wang, P., Zhang, X., Shen, F., Gogos, C.G., Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit® E PO solid dispersions. Int. J. Pharm. 383 (2010), 161–169, 10.1016/j.ijpharm.2009.09.003.
Luebbert, C., Huxoll, F., Sadowski, G., Van Den Mooter, G., Grohganz, H., Amorphous-amorphous phase separation in API/polymer formulations. Molecules 22 (2017), 1–17, 10.3390/molecules22020296.
Maniruzzaman, M., Boateng, J.S., Snowden, M.J., Douroumis, D., A Review of Hot-Melt Extrusion : Process Technology to Pharmaceutical Products, 2012, 10.5402/2012/436763.
Markopoulos, C., Andreas, C.J., Vertzoni, M., Dressman, J., Reppas, C., In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media. Eur. J. Pharm. Biopharm. 93 (2015), 173–182, 10.1016/j.ejpb.2015.03.009.
Matrose, N.A., Obikese, K., Belay, Z.A., Caleb, O.J., Jo ur na l P re of. Sci. Total Environ., 135907, 2021, 10.1016/j.jddst.2021.102559.
Mendonsa, N., Almutairy, B., Kallakunta, V.R., Sarabu, S., Thipsay, P., Bandari, S., Repka, M.A., Manufacturing strategies to develop amorphous solid dispersions: An overview. J. Drug Deliv. Sci. Technol., 55, 2020, 101459, 10.1016/j.jddst.2019.101459.
Meng, F., Dave, V., Chauhan, H., Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems. Eur. J. Pharm. Sci. 77 (2015), 106–111, 10.1016/j.ejps.2015.05.018.
Meng, F., Trivino, A., Prasad, D., Chauhan, H., Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions. Eur. J. Pharm. Sci. 71 (2015), 12–24, 10.1016/j.ejps.2015.02.003.
Menjoge, A.R., Kulkarni, M.G., Mechanistic investigations of phase behavior in Eudragit®E blends. Int. J. Pharm. 343 (2007), 106–121, 10.1016/j.ijpharm.2007.05.033.
Moseson, D.E., Jordan, M.A., Shah, D.D., Corum, I.D., Alvarenga, B.R. Jr, Taylor, L.S., Application and limitations of thermogravimetric analysis to delineate the hot melt extrusion chemical stability processing window. Int. J. Pharm., 590, 2020, 119916, 10.1016/j.ijpharm.2020.119916.
Nyamba, I., Lechanteur, A., Semdé, R., Evrard, B., Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review. Eur. J. Pharm. Biopharm. 159 (2021), 198–210, 10.1016/j.ejpb.2020.11.004.
Parikh, T., Gupta, S.S., Meena, A.K., Vitez, I., Mahajan, N., Serajuddin, A.T., Application of film-casting technique to investigate drug–polymer miscibility in solid dispersion and hot-melt extrudate. J. Pharm. Sci. 104:7 (2015), 2142–2152, 10.1002/jps.24446.
Price, D.J., Nair, A., Kuentz, M., Dressman, J., Saal, C., Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations. Eur. J. Pharm. Sci. 132 (2019), 142–156, 10.1016/j.ejps.2019.03.006.
Psimadas, D., Georgoulias, P., Valotassiou, V., Loudos, G., Molecular Nanomedicine Towards Cancer. J. Pharm. Sci. 101 (2012), 2271–2280, 10.1002/jps.
Reitz, E., Vervaet, C., Neubert, R.H.H., Thommes, M., Solid crystal suspensions containing griseofulvin-Preparation and bioavailability testing. Eur. J. Pharm. Biopharm. 83 (2013), 193–202, 10.1016/j.ejpb.2012.09.012.
Repka, M.A., Battu, S.K., Upadhye, S.B., Thumma, S., Crowley, M.M., Zhang, F., Martin, C., McGinity, J.W., Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev. Ind. Pharm. 33 (2007), 1043–1057, 10.1080/03639040701525627.
Restrepo-Uribe, L., Ioannidis, N., del Pilar Noriega, M., Dissolution improvement of an active pharmaceutical ingredient in a polymer melt by hot melt extrusion. J. Polym. Eng. 39:2 (2019), 186–196.
Rumondor, A.C.F., Ivanisevic, I., Bates, S., Alonzo, D.E., Taylor, L.S., Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm. Res. 26 (2009), 2523–2534, 10.1007/s11095-009-9970-7.
Saboo, S., Moseson, D.E., Kestur, U.S., Taylor, L.S., Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers. Eur. J. Pharm. Sci., 155, 2020, 105514, 10.1016/j.ejps.2020.105514.
Salmani, J.M.M., Lv, H., Asghar, S., Zhou, J., Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: A successful approach to improve the bioavailability of atorvastatin. Pharm. Dev. Technol. 20 (2015), 465–472, 10.3109/10837450.2014.882938.
Sarode, A.L., Sandhu, H., Shah, N., Malick, W., Zia, H., Hot melt extrusion (HME) for amorphous solid dispersions: Predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur. J. Pharm. Sci. 48 (2013), 371–384, 10.1016/j.ejps.2012.12.012.
Sarode, A.L., Obara, S., Tanno, F.K., Sandhu, H., Iyer, R., Shah, N., Stability assessment of hypromellose acetate succinate (HPMCAS) NF for application in hot melt extrusion (HME). Carbohydr. Polym. 101 (2014), 146–153, 10.1016/j.carbpol.2013.09.017.
Savic, I.M., Jocic, E., Nikolic, V.D., Popsavin, M.M., Srdjan, J., Savic-gajic, I.M., Savic, I.M., Jocic, E., Nikolic, V.D., Popsavin, M.M., The effect of complexation with cyclodextrins on the antioxidant and antimicrobial activity of ellagic acid. Pharm. Dev. Technol. 24 (2019), 410–418, 10.1080/10837450.2018.1502318.
Shadambikar, G., Kipping, T., Di-Gallo, N., Elia, A.G., Knüttel, A.N., Treffer, D., Repka, M.A., Vacuum compression molding as a screening tool to investigate carrier suitability for hot-melt extrusion formulations. Pharmaceutics 12 (2020), 1–17, 10.3390/pharmaceutics12111019.
Shamma, R.N., Basha, M., Soluplus®: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technol. 237 (2013), 406–414, 10.1016/j.powtec.2012.12.038.
Školáková, T., Souchová, L., Patera, J., Pultar, M., Školáková, A., Zámostný, P., Prediction of drug-polymer interactions in binary mixtures using energy balance supported by inverse gas chromatography. Eur. J. Pharm. Sci. 130 (2019), 247–259, 10.1016/j.ejps.2019.01.021.
Soh, P.N., Witkowski, B., Olagnier, D., Nicolau, M.L., Garcia-Alvarez, M.C., Berry, A., Benoit-Vical, F., In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob. Agents Chemother. 53 (2009), 1100–1106, 10.1128/AAC.01175-08.
Spoerk, M., Koutsamanis, I., Kottlan, A., Makert, C., Piller, M., Rajkovaca, M., Paudel, A., Khinast, J., Continuous Processing of Micropellets via Hot-melt Extrusion. AAPS PharmSciTech, 1–14, 2022, 10.1208/s12249-022-02405-7.
Tambosi, G., Coelho, P.F., Soares, L., Lenschow, I.C.S., Zétola, M., Stulzer, H.K., Pezzini, B.R., Challenges to improve the biopharmaceutical properties of poorly water-soluble drugs and the application of the solid dispersion technology. Rev. Mater., 23, 2018, 10.1590/s1517-707620180004.0558.
Thiry, J., Lebrun, P., Vinassa, C., Adam, M., Netchacovitch, L., Ziemons, E., Hubert, P., Krier, F., Evrard, B., Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination. Int. J. Pharm. 515 (2016), 114–124, 10.1016/j.ijpharm.2016.10.003.
Thiry, J., Kok, M.G.M., Collard, L., Frère, A., Krier, F., Fillet, M., Evrard, B., Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Eur. J. Pharm. Sci. 99 (2017), 1–8, 10.1016/j.ejps.2016.12.001.
Thommes, M., Ely, D.R., Carvajal, M.T., Pinal, R., Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions. Mol. Pharm. 8 (2011), 727–735, 10.1021/mp1003493.
Tian, Y., Jacobs, E., Jones, D.S., McCoy, C.P., Wu, H., Andrews, G.P., The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platform. Int. J. Pharm., 586, 2020, 119545, 10.1016/j.ijpharm.2020.119545.
Tran, P.H.L., Lee, B.-J., Tran, T.T.D., Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion. Eur. J. Pharm. Biopharm. 164 (2021), 13–19, 10.1016/j.ejpb.2021.04.009.
Tran, P., Park, J.S., Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs. Int. J. Pharm., 610, 2021, 121247, 10.1016/j.ijpharm.2021.121247.
Tran, P., Pyo, Y.C., Kim, D.H., Lee, S.E., Kim, J.K., Park, J.S., Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics 11 (2019), 1–26, 10.3390/pharmaceutics11030132.
Vo, C.L., Park, C., Lee, B., European Journal of Pharmaceutics and Biopharmaceutics Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 85 (2013), 799–813, 10.1016/j.ejpb.2013.09.007.
Wilson, M., Williams, M.A., Jones, D.S., Andrews, G.P., Hot-melt extrusion technology and pharmaceutical application. Ther. Deliv. 3 (2012), 787–797, 10.4155/tde.12.26.
Yuan, L., Mei, L., Guan, X., Hu, Y., Ellagic acid solid dispersion: Characterization and bioactivity in the hydroxyl radical oxidation system. Food Res. Int., 142, 2021, 110184, 10.1016/j.foodres.2021.110184.
Zazueta, C., Ellagic acid : Pharmacological activities and molecular mechanisms involved in liver protection 97 (2015), 84–103, 10.1016/j.phrs.2015.04.008.
Zhang, J., Yang, W., Vo, A.Q., Feng, X., Ye, X., Kim, D.W., Repka, M.A., Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation. Carbohydr. Polym. 177 (2017), 49–57, 10.1016/j.carbpol.2017.08.058.
